Dr. Farwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-7750
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Nuclear Radiology, 2012 - 2013- New York Presbyterian Hospital (Columbia Campus)Residency, Radiology-Diagnostic, 2008 - 2012
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2007 - 2008
Columbia University Vagelos College of Physicians and SurgeonsClass of 2007
Certifications & Licensure
NJ State Medical License 2014 - 2025
PA State Medical License 2013 - 2024
NY State Medical License 2008 - 2013- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- [F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status.Joanna K Weeks, Austin R Pantel, Sarah B Gitto, Fang Liu, Erin K Schubert
Journal of Nuclear Medicine. 2024-12-05 - Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-TargetedF-Fluorthanatrace PET in Breast Cancer.Anthony J Young, Austin R Pantel, Mahsa Kiani, Robert K Doot, Sina Bagheri
Journal of Nuclear Medicine. 2024-12-03 - 3 citationsCombination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8T cells.Kevin Wang, Paulina Coutifaris, David Brocks, Guanning Wang, Tarek Azar
Cancer Cell. 2024-09-09
Press Mentions
Two Penn Physicians Awarded SU2C Immuno-Oncology Innovative Research GrantsApril 3rd, 2017
FDG PET/CT Imaging After Just One Week May Predict Treatment Response in Patients with Advanced MelanomaJanuary 24th, 2024- Imaging Just One Week After Starting Treatment Can Predict Melanoma Response to ImmunotherapyJanuary 25th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
